Rocket Pharmaceuticals Inc. logo

Rocket Pharmaceuticals Inc. (RCKT)

Market Closed
1 Sep, 20:00
NASDAQ (NMS) NASDAQ (NMS)
$
3. 73
+0.01
+0.2688%
After Hours
$
3. 80
+0.07 +1.8767%
406.2M Market Cap
- P/E Ratio
- Div Yield
948,530 Volume
-3.06 Eps
$ 3.72
Previous Close
Add Transaction
Day Range
3.67 3.81
Year Range
2.53 5.45
Want to track RCKT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Rocket Pharmaceuticals Inc. (RCKT) Statistics

Valuation metrics

Market Cap 406.2M
Enterprise value 221.78M
Trailing P/E (ttm) -24.13
Forward P/E -
PEG ratio -0.16
Price/Sales (ttm) -
Price/Book (mrq) 1.18
Enterprise Value/Revenue -
Enterprise Value/EBITDA 27.89

Overview

Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 3.45M
Average volume (90 days) 2.12M

Price summary

52-Week low 2.53
52-Week high 5.45
Beta -
50-Day moving average 3.6
200-Day moving average 3.82

Dividends and splits

Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:4
Last split Date 5 Jan 2018

Financials

Fiscal year

Fiscal year ends -
Most recent quarter (mrq) -

Profitability

Profit margin -
Operating margin -

Operational effectiveness

Return on assets -0.04%
Return on equity -0.06%

Income Statement

Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.15
Quarterly earnings growth (yoy) -

Balance Sheet

Total cash (mrq) -
Total cash per share (mrq) 2.51
Total debt (mrq) -
Total Debt/Equity (mrq) 0.07
Current ratio (mrq) 9.24%
Book value per share (mrq) 3.27

Cash Flow

Cash flow statement -
Levered free cash flow (LFCF) -